Hua Shan
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hua Shan.
The Lancet | 2002
Hua Shan; Jing Xing Wang; Fu Rong Ren; Yuan Zhi Zhang; Hai Yan Zhao; Guo Jing Gao; Yang Ji; Paul M. Ness
While transfusion-transmissible diseases, including AIDS and viral hepatitis, continue to spread especially in developing countries, the issue of safeguarding the worlds blood supply is of paramount importance. China houses more than 20% of the earths population, and thus its blood supply has the potential to affect the global community. In recent years, Chinese blood centres have tried to improve the nations blood safety. Although substantial progress has already been made, many daunting difficulties remain. Traditional cultural barriers need to be overcome to successfully mobilise volunteer blood donors. Gaps in information and technology still need to be closed. Insufficiency of economic resources also restrict the blood bank industry. Other developing countries face many of the same challenges as China.
Transfusion | 2014
Steven H. Kleinman; Michael P. Busch; Edward L. Murphy; Hua Shan; Paul M. Ness; Simone A. Glynn
The Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III) is a 7‐year multicenter transfusion safety research initiative launched in 2011 by the National Heart, Lung, and Blood Institute.
Transfusion | 2007
Geoffrey H. Tison; Changli Liu; Furong Ren; Kenrad E. Nelson; Hua Shan
BACKGROUND: For the past several decades, Chinese blood centers have relied on blood donations from employer‐organized donors (blood donors who donate blood in groups with coworkers as prearranged by the employer and the local blood center). Recently the government has decided to phase out employer‐organized donors and transition to the use of only volunteer donors (blood donors who donate individually independent of employers). Evaluating the beliefs and attitudes of employer‐organized and volunteer donors is critical to maintain an adequate blood supply after this transition.
Transfusion | 2014
Furong Ren; Chenyan Zhao; Ling Wang; Zhuoyan Wang; Xiaoyan Gong; Meilan Song; Hui Zhuang; Yi Huang; Hua Shan; Jingxing Wang; Qiang Liu; Paul M. Ness; Kenrad E. Nelson; Youchun Wang
The risk of hepatitis E virus (HEV) infection from blood transfusion has aroused increasing concern in many countries. The aim of this study was to analyze the potential risk of HEV infection through blood transfusion in China.
Transfusion | 2007
Hua Shan; Fu Rong Ren; Hai Yan Zhao; Yuan Zhi Zhang; Guo Xing Wen; Fu Zhu Yao; Guo Jing Gao; Li Xing Yan; Chao Fu Jiang; Xu Hua Bai; Mei Hei Li Tiemuer; Yuan Quan Tu; Fa Ming Zhu; You Rong Zheng; Li Cui; Chang Li Liu; Xiao Yan Gong; Qiu Shuang Lv; Peng Zheng; Rainer Ziermann; Paul C. Van Ness; Jing Xing Wang
BACKGROUND: A multi–blood center study was conducted to evaluate a human immunodeficiency virus type 1 (HIV‐1) and hepatitisu2003C virus (HCV) multiplex nucleic acid testing (NAT) donor screening test and to determine the residual risk for HIV‐1 and HCV infection.
Transfusion | 2005
Fu Rong Ren; Qiu Shuang Lv; Hui Zhuang; Jing Jing Li; Xiao Yan Gong; Guo Jing Gao; Chang Li Liu; Jing Xing Wang; Fu Zhu Yao; You Rong Zheng; Fa Ming Zhu; Mei Hei Li Tiemuer; Xu Hua Bai; Hua Shan
BACKGROUND: The correlation between signal‐to‐cutoff (S/CO) ratios of a second‐generation hepatitisu2003C virus (HCV) enzyme immunoassay (EIA; Abbott) and a third‐generation HCV enzyme‐linked immunosorbent assay (ELISA; Ortho) and confirmed HCV infection has been reported. The utility of the values for the Chinese anti‐HCV EIA kits, however, has not been studied in evaluating test results in Chinese blood donors.
Transfusion | 2006
Nickolas Zaller; Kenrad E. Nelson; Paul C. Van Ness; Guoxing Wen; Turgun Kewir; Xuhua Bai; Hua Shan
BACKGROUND: The recruitment and retention of voluntary, nonremunerated blood donors continues to be a challenge in China. Understanding donor demographics and donor characteristics is crucial for any blood center in developing strategies to recruit potential donors.
Transfusion | 2010
Jing Liu; Yi Huang; Jingxing Wang; Xinhong Bi; Julin Li; Yunlai Lü; Xiuqiong Wen; Fuzhu Yao; Xiangdong Dong; Weilan He; Mei Huang; Hongli Ma; Heili Mei; Melissa King; David Wright; Paul M. Ness; Hua Shan
BACKGROUND: On May 12, 2008, a severe earthquake struck Chinas Sichuan Province. The nationwide outpouring of charity resulted in a surge of subsequent blood donations. The quantity and quality of these donations were examined in comparison with routine donations.
Transfusion | 2015
Peibin Zeng; Lili Ma; Zhan Gao; Jingxing Wang; Jing Liu; Xianwei Huang; Qizhi Yang; Ruan Cao; Xiuqiong Wen; Lili Zhu; Hongli Ma; Zhendong Yang; Tzong Hae Lee; Donald Brambilla; Michelle Yuan; Simone A. Glynn; Paul M. Ness; Steve Kleinman; Michael P. Busch; Hua Shan
Severe fever with thrombocytopenia syndrome virus (SFTSV), an emerging tick‐borne pathogen that can cause fatal severe fever with thrombocytopenia syndrome, was first identified in China in 2009. Limited evidence suggests that SFTSV can be transmitted between humans via blood contact, raising concerns over transfusion safety. A study of donor samples from three Chinese blood centers was conducted to investigate the seroprevalence and rate of SFTSV viremia among Chinese blood donors.
Vox Sanguinis | 2012
Nan Guo; Jingxing Wang; Paul M. Ness; F. Yao; Xinhong Bi; Julin Li; Zhongqiao Yun; Xiaoming Guo; Yi Huang; Xiangdong Dong; Mei-hei-li Tiemuer; Weilan He; Hongli Ma; Mei Huang; Jing Liu; David J. Wright; Kenrad E. Nelson; Hua Shan
Backgroundu2002 On 12 May 2008, a severe earthquake struck Sichuan in China. Many people donated blood for the first time, leading us to question whether these donors might become repeat donors in the future. The return pattern of post‐earthquake first‐time donors (PEFTD) was compared with that of first‐time donors (FTD) in a comparable period.